The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD
Phase 2
Recruiting
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
- Interventions
- Drug: Oral Placebo
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Bazelet Nehushtan LtD.
- Target Recruit Count
- 120
- Registration Number
- NCT06542445
- Locations
- 🇮🇱
Shamir Medical Center, Zerifin, Israel
© Copyright 2025. All Rights Reserved by MedPath